Related Experiment Video
Updated: Oct 13, 2026

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
Published on: September 12, 2014
Clonazepam in the treatment of prepubertal children with panic-like symptoms
1Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
Insights
Clonazepam effectively treated severe anxiety disorders in three children, rapidly controlling panic-like symptoms without adverse effects. Follow-up showed sustained symptom remission, suggesting its therapeutic potential for pediatric anxiety.
Area of Science:
- Child and Adolescent Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Severe anxiety disorders and panic-like symptoms can be debilitating in prepubertal children.
- Limited empirical data exists on the efficacy of specific pharmacological interventions for childhood anxiety disorders.
Observation:
- Three prepubertal children with severe, incapacitating anxiety disorders and panic-like symptoms were identified.
- These children were treated with clonazepam, with daily doses ranging from 0.5 to 3 mg.
Findings:
- Clonazepam rapidly controlled anxiety and panic-like symptoms once a therapeutic dose was achieved.
- No adverse effects were reported during the treatment period.
- All three children remained symptom-free at follow-up periods ranging from 5 months to 3 years.
Implications:
- These cases suggest a diagnostic and therapeutic overlap between childhood and adult anxiety disorders.
- The findings highlight the need for empirical studies to evaluate diagnostic criteria and treatment strategies for childhood anxiety disorders.
- Clonazepam may be a viable treatment option for severe childhood anxiety disorders, warranting further investigation.
Abstract:
Three prepubertal children who suffered severe, incapacitating anxiety disorders with panic-like symptoms were treated successfully with clonazepam. The daily doses ranged from 0.5 to 3 mg. Symptoms were rapidly controlled after a therapeutic dose was attained, and no adverse effects were reported. The children were symptom-free at follow-up, which ranged from 5 months to 3 years. These three cases illustrate the diagnostic and therapeutic overlap between childhood and adult anxiety disorders and indicate the need for empirical studies aimed at evaluating diagnostic and treatment issues in childhood anxiety disorders.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Panic Disorder
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...